Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Paragraphs

To assess the benefits of intervention programs against Helicobacter pylori infection, we estimated the baseline curves of its incidence and prevalence. We developed a mathematical (compartmental) model of the intrinsic dynamics of H. pylori, which represents the natural history of infection and disease progression. Our model divided the population according to age, infection status, and clinical state. Case-patients were followed from birth to death. A proportion of the population acquired H. pylori infection and became ill with gastritis, duodenal ulcer, chronic atrophic gastritis, or gastric cancer. We simulated the change in transmissibility consistent with the incidence of gastric cancer and duodenal ulcer over time, as well as current H. pylori prevalence. In the United States, transmissibility of H. pylori has decreased to values so low that, should this trend continue, the organism will disappear from the population without targeted intervention; this process, however, will take more than a century.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Emerging Infectious Diseases
Authors
Ross D. Shachter
Douglas K. Owens
Julie Parsonnet

A major step in the improvement of health care quality is the development of measures of quality that rely upon routinely collected information about office visits and hospital care. In an effort to improve quality measurement, the Quality and Patient Safety Indicators project evaluates methods for measuring quality by using routinely collected information about hospitalized patients.

The TECH project is an international collaboration aimed at understanding patterns of technology adoption and diffusion of medical care and the effects of these patterns on patient outcomes. The team, organized from 17 developed countries, is exploring whether individuals living in countries that rapidly adopted new revascularization technologies and clot-dissolving drugs are more likely to survive heart attacks than individuals living in countries that have adopted such interventions more slowly.

The TECH project has three specific goals:

Paragraphs

BACKGROUND: Cigarette smoking is a major risk factor for several chronic oxidative diseases that can be ameliorated by antioxidants.

OBJECTIVES: This study identified the typical dietary intakes and the major food group contributors of the antioxidants beta-carotene, vitamin C, and vitamin E by smoking status.

DESIGN: The 1994-1996 Continuing Survey of Food Intakes by Individuals (CSFII) provided the current sample (n = 6749), who were categorized as non- (n = 3231), former (n = 1684), and current (n = 1834) smokers. In the CSFII, individuals' food intakes were estimated with two 24-h dietary recalls. Data were analyzed by using a chi-square test with a simultaneous Fisher's z test, analysis of variance with Scheffe's test, multivariate analysis of covariance, and analysis of covariance with Bonferroni adjustment for multiple comparisons.

RESULTS: The sample consisted of 3707 men and 3042 women. Current smokers tended to be younger with less education and lower incomes than nonsmokers and former smokers. The average body mass index (in kg/m(2)) of current smokers was 25.8, the lowest of the 3 groups. Current smokers had the lowest dietary antioxidant intake. Fatty foods such as luncheon meats, condiments and salad dressings, and ground beef contributed more to the antioxidant intakes of current smokers than to those of the other 2 groups, whereas fruit and vegetables contributed less. Current smokers consumed the fewest numbers of servings of all nutrient-bearing groups in the food guide pyramid, except the meat group.

CONCLUSION: Future interventions should target the clustering of cigarette smoking and other unhealthy lifestyle habits, eg, an imprudent diet.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
American Journal of Clinical Nutrition
Authors
Paragraphs

Several recent studies have made clear that drug expenditures are rising more rapidly than other health care spending. What has not been clear, however, is how much drug spending is driven by price rather than volume and whether volume increases are appropriate. This DataWatch takes a closer look at the components and drivers of drug spending using large claims databases from managed care and employer-sponsored health benefit plans. In both environments this study found volume, not price, to be the largest driver of drug spending for seven diseases studied. For four of the diseases, we review the clinical issues that may have influenced volume growth.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Health Affairs
Authors

Encina Commons, Room 190
615 Crothers Way,
Stanford, CA 94305-6006

(650) 723-0570
0
Professor, Health Policy
Professor, Medicine
Professor, Stanford Graduate School of Business (by courtesy)
Senior Fellow, by courtesy, Freeman Spogli Institute for International Studies
sarah_singer_head-2023.jpg PhD, MBA

Sara Singer, PhD, MBA, is a professor of health policy at the Stanford University School of Medicine and Professor by courtesy at the Stanford Graduate School of Business. She is the faculty director of the Health Leadership, Innovation, and Organizations (HELIO) Labs, which fosters interdisciplinary collaboration among colleagues from across the University, including Stanford Health Care and the Schools of Medicine, Business, Engineering, Design, Sustainability, Law, and Humanities and Sciences — and across the globe.

Singer's research in the field of health care management and policy is informed by her interdisciplinary training in health policy, organizational behavior, and general management. Using innovative mixed methods and organizational theories, she studies health-care teams and organizations to understand how leaders and policymakers can improve the safety and quality of health-care delivery through changes in institutional culture, leadership, organizational design, and team dynamics. Her research program is built around central challenges in health-care delivery (ensuring patient safety despite enormous complexity and uncertainty in diagnosis, treatment, and disease progression; integrating increasingly fragmented services across multiple service providers and organizations; and implementing, adapting, and sustaining innovations that enhance the value of health care), where my research suggests that learning- and systems-oriented leaders and teams and supportive organizational cultures are critical factors for creating a high performing health care delivery system.

Sara Singer on Communication in Health Care

CV
Date Label

Department of Radiology
Stanford Medical Center
Lucas P267
Stanford, CA 94305-5488

(650) 498-5261
0
Professor of Radiology
Professor of Management Science and Engineering (by courtesy)
photo_sylvia_plevritis_0101a.jpg PhD

Sylvia Plevritis is a professor of radiology and, by courtesy, of Management Science and Engineering. Her work involves the development of novel computational and informatics tools, relying on multi-modality, high-throughput data of molecular cancer signatures, in-vivo images and clinical outcomes.

Stanford Health Policy Associate
Subscribe to Health and Medicine